The House Judiciary Committee’s Republican majority is demanding documents from the Federal Trade Commission regarding what they call the agency’s “unusual approach” in opposing the Illumina-Grail merger.

Judiciary Committee Chair Jim Jordan, R-Ohio, sent a letter to FTC Chair Lina Khan on Thursday claiming the agency improperly shared information with the European Commission that led the foreign regulators to deny the proposed acquisition of Grail, a maker of cancer diagnostic tests, by Illumina, a biotechnology company. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]